Fresh turmoil at the FDA with Prasad’s exit - Poll - MDSpire

Fresh turmoil at the FDA with Prasad’s exit

  • By

  • Sarah Todd

  • March 9, 2026

  • 0 min

Share

Original Source(s)

Fresh turmoil at the FDA with Prasad’s exit

  • by Sarah Todd

  • March 9, 2026

Related Content

Invisible Disabilities in Medical Education: The Oversights and Their Impact on Patients

Cost-Effectiveness Analysis of a Comprehensive Obesity Prevention Program in Primary Schools in China

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.